Regulation of bone sialoprotein mRNA by steroid hormones

J Cell Biol. 1989 Dec;109(6 Pt 1):3183-6. doi: 10.1083/jcb.109.6.3183.

Abstract

In this report we demonstrate an increase in the steady-state level of bone sialoprotein (BSP) mRNA in rat calvaria and a rat osteosarcoma cell line (ROS 17/2.8) after treatment with the synthetic glucocorticoid, dexamethasone. In contrast, 1.25-dihydroxyvitamin D3 reduced the amount of BSP mRNA in calvaria and inhibited the dexamethasone induction in ROS 17/2.8 cells. The increase in BSP mRNA is most likely due to an increase in the transcriptional rate. The stability of mRNA was unchanged after dexamethasone treatment with a half-life of approximately 5 h. Nuclear transcription experiments with nuclei isolated from ROS 17/2.8 cells showed an increased BSP mRNA synthesis in cells treated with dexamethasone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Bone and Bones / drug effects
  • Bone and Bones / metabolism*
  • Calcitriol / pharmacology
  • Cell Line
  • Cells, Cultured
  • Dexamethasone / pharmacology*
  • Gene Expression Regulation / drug effects*
  • Genes / drug effects*
  • Integrin-Binding Sialoprotein
  • Osteosarcoma
  • RNA, Messenger / drug effects
  • RNA, Messenger / genetics*
  • Rats
  • Sialoglycoproteins / genetics*
  • Transcription, Genetic / drug effects*

Substances

  • Ibsp protein, rat
  • Integrin-Binding Sialoprotein
  • RNA, Messenger
  • Sialoglycoproteins
  • Dexamethasone
  • Calcitriol